Finding New Ways to Overcome Resistant Lung Cancer
The identification of two mutations that cause resistance to a lung cancer therapy may lead to new treatment options for patients with ALK-positive disease.
Progress Against Cancer
The identification of two mutations that cause resistance to a lung cancer therapy may lead to new treatment options for patients with ALK-positive disease.
A study found why some patients with mantle cell lymphoma develop resistance to the drug ibrutinib. The finding that could help researchers identify new treatment options. Mantle cell lymphoma is a rare type of...
A study found that an investigational Human papillomavirus (HPV) vaccine could prevent nearly 90 percent of cervical cancers.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More